Risk factor |
Score | |
Age | ||
41-60 years |
1 | |
61-74 years |
2 | |
≥75 years |
3 | |
BMI >25 kg/m2 |
1 | |
Women | ||
Oral contraceptives or HRT |
1 | |
Pregnancy or postpartum |
1 | |
History of unexplained or recurrent miscarriage/stillborn infant |
1 | |
Thrombophilia | ||
Elevated serum homocysteine |
3 | |
Positive factor V Leiden mutation |
3 | |
Positive prothrombin 20210A mutation |
3 | |
Positive lupus anticoagulant |
3 | |
Positive anticardiolipin antibodies |
3 | |
Positive anti–beta2-GPI antibodies |
3 | |
HIT |
3 | |
Other congenital or acquired thrombophilia |
3 | |
Venous disease | ||
Lower limb edema |
1 | |
Varicose veins of lower limb |
1 | |
History of VTE |
3 | |
Family history of VTE |
3 | |
Immobilization |
| |
Medical patient currently at bed rest |
1 | |
Patient confined to bed (>72 h) |
2 | |
Limb immobilized in plaster cast |
2 | |
Surgery | ||
Minor surgery planned |
1 | |
Arthroscopic surgery |
2 | |
Major surgery (>45 min) |
2 | |
Laparoscopic surgery (>45 min) |
2 | |
Elective arthroplasty |
5 | |
Hip, pelvis, or leg fracture |
5 | |
Other | ||
Sepsis (<1 month) |
1 | |
Serious lung disease, including pneumonia (<1 month) |
1 | |
Abnormal pulmonary function |
1 | |
Acute myocardial infarction |
1 | |
Onset or exacerbation of heart failure (<1 month) |
1 | |
History of inflammatory bowel disease |
1 | |
Central venous access |
2 | |
Malignancy |
2 | |
Stroke (<1 month) |
5 | |
Acute spinal cord injury (<1 month) |
5 | |
Interpretation of risk level: Score 0: Very low risk Score 1-2: Low risk Score 3-4: Moderate risk Score ≥5: High risk | ||
Adapted from Chest. 2012;141(2 Suppl):e227S-e277S. | ||
Anti–beta2-GPI, anti–beta2-glycoprotein I; BMI, body mass index; HIT, heparin-induced thrombocytopenia; HRT, hormone replacement therapy; VTE, venous thromboembolism. |